Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference

NEXT STORY
Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj), for the Treatment of Patients with Multiple Myeloma
PREV STORY
TELUS and Koodo giving two months free wireless service to frontline staff at Vancouver Coastal Health and Fraser Health Authority
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arch Oncology Appoints Ronald Krasnow, Esq. as Chief Operating Officer

author_avatar
NASDAQ Market News

Immutep to Collaborate with LabCorp to Develop Oncology Services and Products

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Completes Gastric Fluid Testing of Brilacidin Supporting Development of an Oral Dosage Form to Treat Inflammatory Bowel Disease

BEVERLY, Mass., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News